229 related articles for article (PubMed ID: 29932302)
1. Propranolol versus steroids for the treatment of ulcerated infantile hemangiomas.
Polites SF; Rodrigue BB; Chute C; Hammill A; Dasgupta R
Pediatr Blood Cancer; 2018 Oct; 65(10):e27280. PubMed ID: 29932302
[TBL] [Abstract][Full Text] [Related]
2. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
3. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
4. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
[TBL] [Abstract][Full Text] [Related]
5. Infantile hemangiomas, complications and treatments.
Cheng CE; Friedlander SF
Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
[TBL] [Abstract][Full Text] [Related]
6. Early propranolol treatment of infantile hemangiomas improves outcome.
Giachetti A; Díaz MS; Boggio P; Posadas Martínez ML
An Bras Dermatol; 2023; 98(3):310-315. PubMed ID: 36577593
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.
Kim KH; Choi TH; Choi Y; Park YW; Hong KY; Kim DY; Choe YS; Lee H; Cheon JE; Park JB; Park KD; Kang HJ; Shin HY; Jeong JH
JAMA Dermatol; 2017 Jun; 153(6):529-536. PubMed ID: 28423174
[TBL] [Abstract][Full Text] [Related]
8. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.
Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
11. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
12. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.
Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J
Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
14. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S
Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
[TBL] [Abstract][Full Text] [Related]
15. Propranolol for infantile hemangiomas in developing countries.
McMichael J; Lawley LP
Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329512
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
18. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
19. [Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma].
Rodríguez-Ruiz M; Tellado MG; del Pozo Losada J
An Pediatr (Barc); 2016 Feb; 84(2):92-6. PubMed ID: 26002439
[TBL] [Abstract][Full Text] [Related]
20. [What's new about infantile hemangiomas?].
Dreyfus I; Maza A; Mazereeuw-Hautier J
Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
